ADAM17 Polyclonal Antibody

ADAM17 Polyclonal Antibody

The ADAM17 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of ADAM17 protein expression in various biological samples. ADAM17, also known as tumor necrosis factor-alpha converting enzyme (TACE), is a membrane-bound metalloprotease that plays a crucial role in the shedding of various cell surface proteins, including cytokines, growth factors, and receptors. This antibody has been extensively validated for its specificity and sensitivity in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications.

The ADAM17 polyclonal antibody exhibits exceptional affinity towards the target protein, ensuring accurate and reproducible results. It has been rigorously tested against a wide range of cell lines and tissues, demonstrating its versatility and reliability in different experimental settings. This antibody recognizes both the pro-form and active form of ADAM17, enabling comprehensive analysis of its expression and activation status.

With its superior performance, the ADAM17 polyclonal antibody is an invaluable tool for researchers studying ADAM17-mediated signaling pathways and its involvement in various physiological and pathological processes. Its application extends to fields such as cancer research, inflammation, and cardiovascular diseases, where ADAM17 has been implicated in disease progression and therapeutic resistance.

The ADAM17 polyclonal antibody is supplied as a purified and lyophilized product, ensuring long-term stability and ease of storage. It is compatible with a variety of detection systems and can be used in combination with other antibodies for multiplex analysis. Each batch of this antibody undergoes stringent quality control measures to guarantee consistent performance and batch-to-batch reproducibility.

In summary, the ADAM17 polyclonal antibody is a highly specific, reliable, and versatile tool for the detection and analysis of ADAM17 protein expression. Its exceptional performance and extensive validation make it an essential reagent for researchers investigating ADAM17-related biology and its implications in various diseases.